Nasal Esketamine in addition to oral Antidepressants: Aid with treatment-resistant Depression?

被引：0
|
作者：
Lenz, Bernd [1 ]
机构：
[1] Univ Klinikum Erlangen, Psychiatr & Psychotherapeut Klin, Erlangen, Germany
来源：
FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE | 2019年 / 87卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：604 / 605
页数：2
相关论文
共 50 条
  • [31] Perspectives in treatment-resistant depression: esketamine and electroconvulsive therapy
    Baldinger-Melich, Pia
    Spies, Marie
    Bozic, Ina
    Kasper, Siegfried
    Rujescu, Dan
    Frey, Richard
    WIENER KLINISCHE WOCHENSCHRIFT, 2024, 137 (5) : 134 - 147
  • [32] Adjunctive dopaminergic enhancement of esketamine in treatment-resistant depression
    Cook, John
    Halaris, Angelos
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2022, 119
  • [33] Cost-Effectiveness of Esketamine Nasal Spray for Patients With Treatment-Resistant Depression in the United States
    Ross, Eric L.
    Soeteman, Djora, I
    PSYCHIATRIC SERVICES, 2020, 71 (10) : 988 - 997
  • [34] Efficacy of Esketamine Nasal Spray Plus Oral Antidepressant Treatment for Relapse Prevention in Patients With Treatment-Resistant Depression A Randomized Clinical Trial
    Daly, Ella J.
    Trivedi, Madhukar H.
    Janik, Adam
    Li, Honglan
    Zhang, Yun
    Li, Xiang
    Lane, Rosanne
    Lim, Pilar
    Duca, Anna R.
    Hough, David
    Thase, Michael E.
    Zajecka, John
    Winokur, Andrew
    Divacka, Ilona
    Fagiolini, Andrea
    Cubala, Wieslaw J.
    Bitter, Istvan
    Blier, Pierre
    Shelton, Richard C.
    Molero, Patricio
    Manji, Husseini
    Drevets, Wayne C.
    Singh, Jaskaran B.
    JAMA PSYCHIATRY, 2019, 76 (09) : 893 - 903
  • [35] Correction to: Oral esketamine for treatment-resistant depression: rationale and design of a randomized controlled trial
    Sanne Y. Smith-Apeldoorn
    Jolien K. E. Veraart
    Jeanine Kamphuis
    Antoinette D. I. van Asselt
    Daan J. Touw
    Marije aan het Rot
    Robert A. Schoevers
    BMC Psychiatry, 20
  • [36] Relationship Between Dissociation and Antidepressant Effects of Esketamine Nasal Spray in Patients With Treatment-Resistant Depression
    Chen, Guang
    Chen, Li
    Zhang, Yun
    Li, Xiang
    Lane, Rosanne
    Lim, Pilar
    Daly, Ella J.
    Furey, Maura L.
    Fedgchin, Maggie
    Popova, Vanina
    Singh, Jaskaran B.
    Drevets, Wayne C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2022, 25 (04): : 269 - 279
  • [37] Combining antidepressants for treatment-resistant depression: A review
    Lam, RW
    Wan, DDC
    Cohen, NL
    Kennedy, SH
    JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (08) : 685 - 693
  • [38] Is there a role for switching antidepressants in treatment-resistant depression?
    Montgomery, Stuart
    PROGRESS IN NEUROLOGY AND PSYCHIATRY, 2013, 17 (05) : 39 - 40
  • [39] Switching antidepressants for treatment-resistant major depression
    Marangell, LB
    JOURNAL OF CLINICAL PSYCHIATRY, 2001, 62 : 12 - 17
  • [40] Efficacy and Safety of Esketamine Nasal Spray Plus an Oral Antidepressant in Elderly Patients With Treatment-Resistant Depression-TRANSFORM-3
    Ochs-Ross, Rachel
    Daly, Ella J.
    Zhang, Yun
    Lane, Rosanne
    Lim, Pilar
    Morrison, Randall L.
    Hough, David
    Manji, Husseini
    Drevets, Wayne C.
    Sanacora, Gerard
    Steffens, David C.
    Adler, Caleb
    McShane, Rupert
    Gaillard, Raphael
    Wilkinson, Samuel T.
    Singh, Jaskaran B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2020, 28 (02): : 121 - 141
12345